The Cooper Companies Inc COO

Morningstar Rating
$56.91 −0.50 (0.87%)
View Full Chart

Company Report

Price vs Fair Value

COO is trading at a LOCK|H#F%kt# premium.
Price
$57.41
Fair Value
&<g
Uncertainty
LOCK|KbF
1-Star Price
LOCK|N.>>
5-Star Price
LOCK|.J
Economic Moat
LOCK|W@tN&
Capital Allocation
LOCK|Gw^TxF

Bulls Say, Bears Say

Bulls

Cooper is one of the leading visioncare companies in the world with a proven record of successful product development. Recent innovations like MiSight widen Cooper's end market and fuel the firm's future growth trajectory.

Bears

While the contact lens market share has been stable, lagging research and innovation could start to chip away at Cooper's presence in the space.

News

Trading Information

Previous Close Price
$57.41
Day Range
$56.72–57.69
52-Week Range
$51.01–89.83
Bid/Ask
$56.26 / $57.56
Shares Outstanding
190.16M
Market Cap
$10.82B
Volume/Avg
3M / 3M

Key Statistics

Price/Earnings (Normalized)
12.46
Price/Sales
2.66
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
5.90%

Company Profile

CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women’s care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Core
Total Number of Employees
15,000

Competitors

Valuation

Metric
COO
ALC
JNJ
Price/Earnings (Normalized)
12.4630.1923.82
Price/Book Value
1.311.437.33
Price/Sales
2.662.896.44
Price/Cash Flow
11.8712.1822.07
Price/Earnings
COO
ALC
JNJ

Financial Strength

Metric
COO
ALC
JNJ
Quick Ratio
0.511.120.73
Current Ratio
1.222.091.09
Interest Coverage
6.184.1925.00
Quick Ratio
COO
ALC
JNJ

Profitability

Metric
COO
ALC
JNJ
Return on Assets (Normalized)
7.25%5.09%13.42%
Return on Equity (Normalized)
10.89%7.28%32.69%
Return on Invested Capital (Normalized)
9.02%6.30%20.33%
Return on Assets
COO
ALC
JNJ

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
LOCK|y?^#$cnLOCK|dNn$142B
Becton Dickinson & Co
BDX
LOCK|tQWLOCK|v!$>Z$49B
ResMed Inc
RMD
LOCK|<n%KxN#LOCK|@@%pm$31B
Medline Inc Ordinary Shares - Class A
MDLN
LOCK|<<@gFWMLOCK|%T#^t$31B
Alcon Inc
ALC
LOCK|J!?!!GlLOCK|HYn@C$31B
West Pharmaceutical Services Inc
WST
LOCK|tmFwJ<gLOCK|YY>$26B
Solventum Corp
SOLV
LOCK|P$>f^FLOCK|Mh$15B
Baxter International Inc
BAX
LOCK|JgdLOCK|Ct?>f$12B
Align Technology Inc
ALGN
LOCK|w&qV#$&LOCK|@vPRQ$10B

Sponsor Center